We discovered that BCR-ABL1 copy numbers in the microvesicles significantly differed between CML patients with different response of TKI (Figure 2B, P = 0.000001), which was consistent with the results of the cellular BCR-ABL1 mRNA tests. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.